Impact of cord clamping timing on calcium levels in newborns
Effects of Timing of Cord Clamping on Serum Calcium Levels in Neonates
This study is testing how waiting different amounts of time to clamp the umbilical cord affects calcium levels in newborns.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 1 Minute to 6 Hours |
| Sex | All |
| Sponsor | College of Physicians and Surgeons Pakistan Academic / other |
| Locations | 1 site (Rawalpindi, Punjab Province) |
| Trial ID | NCT06573333 on ClinicalTrials.gov |
What this trial studies
This study investigates how the timing of umbilical cord clamping affects serum calcium levels in neonates. A total of 200 neonates will be randomly assigned to four groups based on the timing of cord clamping at 15, 30, 60, and 120 seconds. Blood samples will be collected at six hours of life to measure various electrolytes and calcium levels. The aim is to determine if there is a significant difference in serum calcium levels based on the timing of cord clamping.
Who should consider this trial
Good fit: Ideal candidates for this study are neonates born between 37 to 41 weeks of gestation without maternal complications.
Not a fit: Patients who may not benefit include those with maternal clinical diseases or congenital malformations.
Why it matters
Potential benefit: If successful, this study could provide insights into optimal cord clamping practices that may help prevent hypocalcemia in newborns.
How similar studies have performed: Previous research has shown no correlation between cord clamping timing and serum calcium levels, indicating this study may confirm existing findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Neonates born at gestational age 37 weeks to 41 weeks with no maternal complication. Parents who give consent for inclusion in the study Exclusion Criteria: * Mothers with evidence of clinical disease (diabetes, preeclampsia, hypertension). Babies with congenital malformations and intrauterine growth restriction.
Where this trial is running
Rawalpindi, Punjab Province
- Pak Emirates Military Hospital — Rawalpindi, Punjab Province, Pakistan (Recruiting)
Study contacts
- Principal investigator: Arshad Khushdil, MBBS — Military Hospital Rawalpindi
- Study coordinator: Umair Qureshi, MBBS
- Email: umairanees94@gmail.com
- Phone: 0519273480
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.